We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Outcome of Sports Events May Depend on Circadian Rhythms

By LabMedica International staff writers
Posted on 10 Feb 2015
According to a new study, the outcome of sporting events may depend on how well the timing of the match aligns with the internal biological clocks of the athletes, and so could change performance by the hour depending on what time it is for their inner clock. More...


The study, conducted by researchers at University of Birmingham (Birmingham, England), found that diurnal performance of competition-level athletes varied by as much as 26% over the course of the day. Those who would naturally sleep in gave their best performances hours later in the day than early birds. Athletes and coaches would do well to make note and adjust their schedules accordingly as much as possible, the researchers said.

"If a 1% difference in performance can make the difference between 1st place and 4th place in a 100 meter race and actually win you the gold medal at the Olympics, then imagine what a 26% difference in your performance could give," said principal investigator Dr. Roland Brandstaetter. There were earlier reports that suggested that athletes' personal best performances are generally in the evening. But those studies did not account for whether those athletes were of night “owl” or morning “lark” phenotypes. While an individual's circadian phenotype often does shift from childhood into adolescence and adulthood, there are real physiological differences between people based on their natural sleep/wake patterns. These differences result in disparities between their biological clocks and how they entrain to exogenous cues, such as the environmental light/dark cycle and social factors.

In this study, a novel approach was used to characterize the circadian phenotypes of more than 120 athletes. Then 20 athletes were selected representing early, intermediate, and late phenotypes and tested their cardiovascular endurance in a standard fitness test at 6 times of day.

The fitness tests revealed considerable diurnal variation in individual performance. Rather than time-of-day, the best predictor of how well those groups performed at a given hour was the amount of time elapsed since their entrained awakening (i.e., the time since they would have woken up if left to their own devices, without an alarm clock). While an early riser may be at his or her best in the early afternoon, a late riser hits his or her peak much later at night.

The researchers concluded that “determination of an athlete's personal best performance requires consideration of circadian phenotype, performance evaluation at different times of day, and analysis of performance as a function of time since entrained awakening.” This would also be relevant for non-athletic performance – "Obtaining a personal best performance is on everyone's agenda, but how to do it, now that is a different question," said co-author Elise Facer-Childs, and suggested that people would be well-advised to shift significant attention from the clock on the wall to the one that's ticking inside.

The study, by Facer-Childs E. and Brandstaetter R., was published January 29, 2015, in the Cell Press journal Current Biology.

Related Links:

University of Birmingham



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Drug Testing Assays
Atellica DT 250 Analyzer
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.